ArticleBMJ open2022

Cost-effectiveness of recombinant tissue-type plasminogen activator for acute ischaemic stroke with unknown time of onset: a Markov modelling analysis from the Chinese and US perspectives.

Songfeng Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.